RETRACTED: A shared comparison of diabetes mellitus and neurodegenerative disorders
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Diabetes mellitus (DM) is one of the most common diseases in the world population, associated with obesity, pancreatic endocrine changes, cardiovascular disease, renal glomerular disease, cerebrovascular disease, peripheral neuropathy, neurodegenerative disease, retinal disease, sleep apnea, some of which are bundled into the metabolic syndrome. The main characteristic of this disease is hyperglycemia, and often with albuminuria. Nevertheless, the classic features, with ketoacidosis in the extreme, are only a first layer of description of this condition. The description of the islet cells of the endocrine pancreas was first described by Opie, and the discovery of insulin by tying off the exocrine pancreatic ducts followed. We later find that the β‐cells secrete insulin and glucagon, which synchronously stimulate or suppress glycogenolysis, and that insulin is essential for glucose intake into the cell. There are yet two other layers for our understanding of diabetes and the effects of its dysfunction, which is the basis for understanding the system‐wide expression of the disease. We describe the molecular basis for the central nervous system neuropathic diseases that are associated with both Type 1 DM (T1DM) and Type 2 DM (T2DM), but more so with T2DM. T2DM is an autoimmune disease that destroys the insulin secreting islet cells. T2DM is the diabetes that is associated with an imbalance in the glucagon/insulin homeostasis that leads to the formation of amyloid deposits in the brain, pancreatic islet cells, and possibly the kidney glomerulus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer’s disease is type 3 diabetes—Evidence reviewed
de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Crews, L., & Masliah, E. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq160 · Cited by 772 · cited 5×
“In addition, mitochondrial function is impaired, oxidative stress increases, and nigral pathology is enhanced by overexpression of α-synuclein.(4) Respiratory transport chain activity is reduced in HD brains.”
InfluentialThe molecular bases of Alzheimer’s disease and other neurodegenerative disorders
Maccioni, R. B., Muñoz, J. P., & Barbeito, L. (2001) · Archives of Medical Research · doi:10.1016/s0188-4409(01)00316-2 · Cited by 474 · cited 3×
“The authors propose that toxic Aα species may contribute to deregulation of signaling pathways (Fyn, FAK, GSK3b, Cdk5) resulting in alterations to cytoskeletal and synaptic proteins, and subsequent synaptic and neuronal damage.(16) It is important to note that the contributing factors to the impairment of mitochondria…”
Influentialde la Monte, S. M. (2012) · Drugs · doi:10.2165/11597760-000000000-00000 · Cited by 265 · cited 2×
“05).(14) On the other hand, berberine (a natural isoquinoline alkaloid) promoted Aβ clearance and inhibited Aβ production in the triple-transgenic mouse model of AD (3 × Tg-AD), exhibiting a neuroprotective effect on 3 × Tg-AD mice.”
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.11.004 · Cited by 173 · cited 1×
“BECN1 has a role in the assembly of an interactome consisting of diverse proteins responsible for the initiation of autophagocytosis and distinct phases in endocytosis.(12) Impaired autophagy triggers inflammasome activation because anti-apoptotic Bcl-2 family members interact with BECN1, and thus, necrosis factor kap…”
Cited by
Hong, C.-T., Chen, K.-Y., Wang, W., Chiu, J.-Y., Wu, D., Chao, T.-Y., Hu, C.-J., Chau, K.-Y., & Bamodu, O. (2020) · Cells · doi:10.3390/cells9030740 · Cited by 133
(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.02.010 · Cited by 58
Ma, H., He, K., Zhu, J., Li, X., & Ye, X. (2019) · Fitoterapia · doi:10.1016/j.fitote.2019.03.003 · Cited by 37
Dopamine-mediated autocrine inhibition of insulin secretion
Ferrero, E., Masini, M., Carli, M., Moscato, S., Beffy, P., Vaglini, F., Mattii, L., Corti, A., Scarselli, M., Novelli, M., et al. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112294 · Cited by 4
Metadata
- Authors
- Morsi, M., Maher, A., Aboelmagd, O., Johar, D., & Bernstein, L.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2017-09-25
- Volume
- 119
- Issue
- 2
- Pages
- 1249-1256
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2727415474
- Cited by
- 49
- References
- 5
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Status
- Retracted
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: RETRACTED: A shared comparison of diabetes mellitus and neurodegenerative disorders. https://app.cochat.ai/papers/10.1002/jcb.26261
- The paper
- Morsi, M., Maher, A., Aboelmagd, O., Johar, D., & Bernstein, L. (2018). RETRACTED: A shared comparison of diabetes mellitus and neurodegenerative disorders. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.26261
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.